The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Baicalein Protects 6-OHDA-induced Neuronal Damage by Suppressing Oxidative Stress

  • Im, Heh-In (Department of Pharmacology, Seoul National University College of Medicine, Neuroscience Research Institute Medical Research Cent) ;
  • Nam, Eun-Joo (Department of Pharmacology, Seoul National University College of Medicine, Neuroscience Research Institute Medical Research Cent) ;
  • Lee, Eun-Sun (Department of Pharmacology, Seoul National University College of Medicine, Neuroscience Research Institute Medical Research Cent) ;
  • Hwang, Yu-Jin (Department of Pharmacology, Seoul National University College of Medicine, Neuroscience Research Institute Medical Research Cent) ;
  • Kim, Yong-Sik (Department of Pharmacology, Seoul National University College of Medicine, Neuroscience Research Institute Medical Research Cent)
  • Published : 2006.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The protective effects of baicalein, one of the flavonoids in Scutellaria baicalensis Georgi, were evaluated against 6-hydroxydopamine (6-OHDA)-induced neuronal damage in mice and cultured human neuroblastoma cells. Nigrostriatal damage was induced by stereotaxically injecting 6-OHDA into the right striatum. Baicalein was administered intraperitoneally 30 min before and 90 min after lesion induction. Animals received a further daily injection of baicalein for 3 consecutive days. Two weeks after 6-OHDA injection, contralateral rotational asymmetry was observed by apomorphine challenge in lesioned mice. Tyrosine hydroxylase (TH) immunohistochemistry revealed a significant loss of terminals in lesioned striatum and the reduction of the numbers of TH-positive cell in the ipsilateral substantia nigra (SN). In addition, the levels of dopamine (DA) and DA metabolites were reduced and lipid peroxidation was increased in lesioned striatum. However, baicalein treatment reduced apomorphine-induced rotational behavior in 6-OHDA-lesioned mice, and increased TH immunoreactivity in the striatum and SN, and DA levels in lesioned striatum. Lipid peroxidation induced by 6-OHDA was also inhibited by baicalein treatment. Furthermore, when SH-SY5Y human neuroblastoma cells were treated with baicalein, 6-OHDA-induced cytotoxicity and reactive oxygen species (ROS) production were significantly reduced. These results indicate that baicalein effectively protects 6-OHDA-induced neuronal damage through antioxidant action.

Keywords

References

  1. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci 95: 7659-7663, 1998
  2. Bensadoun JC, Mirochnitchenko O, Inouye M, Aebischer P, Zum AD. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur J Neurosci 10: 3231-3236, 1998 https://doi.org/10.1046/j.1460-9568.1998.00345.x
  3. Cai Q, Wei H. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 25: 1-7, 1996 https://doi.org/10.1080/01635589609514423
  4. Carmen LS, Gage FH, Shults CW. Partial lesion of the substantianigra: relation between extent of lesion and rotational behavior. Brain Res 553: 275-283, 1991 https://doi.org/10.1016/0006-8993(91)90835-J
  5. Cohen G, Heikkila RE. The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biochem 249: 2447- 2452, 1974
  6. Datla KP, Christidou M, Widmer WW, Rooprai HK, Dexter DT. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 12: 3871-3875, 2001 https://doi.org/10.1097/00001756-200112040-00053
  7. Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 23: 719-735, 2002 https://doi.org/10.1016/S0197-4580(02)00078-7
  8. Fisher LJ, Jinnah HA, Kale LC, Higgins GA, Gage FH. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron 6: 371-380, 1991 https://doi.org/10.1016/0896-6273(91)90246-V
  9. Gerlach M, Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103: 987-1041,1996 https://doi.org/10.1007/BF01291788
  10. Glinka Y, Gassen M, Youdim MB. Nature of inhibition of mitochondrial respiratory complex 1 by 6-hydroxydopamine. J Neurochem 66: 2004-2010, 1996 https://doi.org/10.1046/j.1471-4159.1996.66052004.x
  11. Glinka Y, Gassen M, Youdim MB. Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm 50(suppl): 55-56, 1997
  12. Hwang YS, Shin CY, Huh Y, Ryu JH. Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats. Life Sci 71: 2105-2117, 2002 https://doi.org/10.1016/S0024-3205(02)01920-3
  13. Iancu R, Mohapel P, Brundin P, Paul G. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 162: 1-10, 2005 https://doi.org/10.1016/j.bbr.2005.02.023
  14. Im HI, Joo WS, Nam E, Lee ES, Hwang YJ, Kim YS. Baicalein prevents 6-OHDA-induced dopaminergic dysfunction and lipid peroxidation in mice. J Phamacol Sci 98: 185-189, 2005
  15. Kim MS, Lee JI, Lee WY, Kim SE. Neuroprotective Effect of Ginkgo biloba L. Extract in a rat model of Parkinson's disease. Phytother Res 18: 663-666, 2004 https://doi.org/10.1002/ptr.1486
  16. Lebeau A, Esclaire F, Rostene W, Pelaprat D. Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. Neuroreport 12: 2199-2202, 2001 https://doi.org/10.1097/00001756-200107200-00031
  17. Lee HH, Yang LL, Wang CC, Hu SY, Chang SF, Lee YH. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res 986: 103- 113, 2003 https://doi.org/10.1016/S0006-8993(03)03197-4
  18. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78: 1073-1082. 2001 https://doi.org/10.1046/j.1471-4159.2001.00490.x
  19. Li FQ, Wang T, Pei Z, Liu B, Hong JS. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation- mediated degeneration of dopaminergic neurons. J Neural Transm 112: 331-347, 2005 https://doi.org/10.1007/s00702-004-0213-0
  20. Luthman J, Herrera-Marschitz M, Lindqvist E. Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behavior and on postmortem monoamine levels. Psychopharmacol 116: 443-450, 1994 https://doi.org/10.1007/BF02247476
  21. Morel I, Lescoat G, Cogrel P, Sergent O, Pasdeloup N, Brissot P, Cillard P, Cillard J. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol 45: 13-19, 1993 https://doi.org/10.1016/0006-2952(93)90371-3
  22. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439-444, 1993 https://doi.org/10.1016/0166-2236(93)90070-3
  23. Onn SP, Berger TW, Stricker EM, Zigmond MJ. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res 376: 8-19. 1986 https://doi.org/10.1016/0006-8993(86)90894-2
  24. Pietta PG. Flavonoids as antioxidants. J Nat Prod 63: 1035-1042, 2000 https://doi.org/10.1021/np9904509
  25. Rebekah JJ, Jonathan TK, Delinda AJ, Jeffrey AJ. Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro. Toxicol Sci 87: 176-186, 2005 https://doi.org/10.1093/toxsci/kfi241
  26. Rice Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22: 375-383, 1995 https://doi.org/10.3109/10715769509145649
  27. Russel J, Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56: 359-384, 1998 https://doi.org/10.1016/S0301-0082(98)00052-5
  28. Ruxandra I, Paul M, Patrik B, Gesine P. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 162: 1-10, 2005 https://doi.org/10.1016/j.bbr.2005.02.023
  29. Saija A, Salese M, Lanza M, Marzullo D, Bonina F, Castelli F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med 19: 481-486, 1995 https://doi.org/10.1016/0891-5849(94)00240-K
  30. Sudheesh S, Sandya C, Sarah Koshy A, Vijayalakshmi NR. Antioxidant activity of flavonoids from Solanum melongena. Phytother Res 13: 393-396, 1999 https://doi.org/10.1002/(SICI)1099-1573(199908/09)13:5<393::AID-PTR474>3.0.CO;2-8
  31. van Acker SA, van Balen GP, van der Berg DJ, Bast A, van der Vijgh WJ. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol 56: 935-943, 1998 https://doi.org/10.1016/S0006-2952(98)00102-6
  32. van Acker SA, van der Berg DJ, Tromp MN, Griffioen DH, van Bennekom WP, van der Vijgh WJ, Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 20: 331-342, 1996 https://doi.org/10.1016/0891-5849(95)02047-0
  33. Wakabayashi I. Inhibitory effects of baicalein and wogonin on lipopolysaccharide induced nitric oxide production in macrophages. Pharmacol Toxicol 84: 288-291, 1999 https://doi.org/10.1111/j.1600-0773.1999.tb01496.x